Berentzen-Gruppe Aktiengesellschaft

  • WKN: 520160
  • ISIN: DE0005201602
  • Land: Deutschland

Nachricht vom 17.02.2017 | 16:29

Berentzen-Gruppe Aktiengesellschaft: Forthcoming changes in Supervisory Board

DGAP-News: Berentzen-Gruppe Aktiengesellschaft / Key word(s): Change of Personnel/Miscellaneous

17.02.2017 / 16:29
The issuer is solely responsible for the content of this announcement.


P R E S S R E L E A S E No. 5/2017

Released for immediate publication

Berentzen-Gruppe Aktiengesellschaft:
Forthcoming changes in Supervisory Board

Haselünne, February 17, 2017 - Berentzen-Gruppe Aktiengesellschaft, listed on the regulated market (General Standard) of the Frankfurt Stock Exchange (ISIN: DE0005201602), has been informed today by three shareholders' members of the Supervisory Board and representatives of the former majority shareholder AURELIUS, Dr Frank Forster (deputy chairman of the Supervisory Board), Dr Dirk Markus and Dr Martin Schoefer, that they would be prematurely resigning from their positions as Supervisory Board members with effect from the end of the company's next regular annual general meeting on 19 May 2017.

The Supervisory Board of Berentzen-Gruppe Aktiengesellschaft will make proposals for nominations to fill the vacant positions on the Supervisory Board at this regular annual general meeting based on a corresponding recommendation by its nominations committee. The election of the new members of the Supervisory Board is to be held for the remaining period of the current term of office of the Supervisory Board, accordingly to the end of the annual general meeting, which will pass a resolution on the approval of the activities of the members of the Supervisory Board for the 2018 financial year.

About the Berentzen Group:
The Berentzen Group is a broad-based beverage company operating in the following three segments: Spirits, Non-alcoholic Beverages and Fresh Juice Systems. The Berentzen Group is one of the oldest producers of spirits in Germany with a corporate history going back over 250 years. Today, it has a presence in more than 60 countries around the world with well-known brands like Berentzen and Puschkin and attractively priced private label products. In its Non-alcoholic Beverages segment, the corporate group produces mineral waters, carbonated and non-carbonated soft drinks under its own brands and also boasts more than 50 years of experience in the franchise business for soft drinks, currently acting as franchisee for the Sinalco brand. In addition, the Berentzen Group markets innovative fresh juice systems under the Citrocasa brand in its third segment, thus serving the fast-growing market for modern, health-oriented drinks. The Berentzen-Gruppe Aktiengesellschaft share (ISIN DE0005201602) is listed on the regulated market (General Standard) of the Frankfurt Stock Exchange.

Further information is available at
www.berentzen-gruppe.de

Berentzen-Gruppe Aktiengesellschaft
Antje Schwindeler
Public Relations / Press
Phone +49 (0) 5961 502 215
pr@berentzen.de



17.02.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

News im Fokus

IRprint: Nachhaltiger Eindruck durch einen professionellen Ausdruck

Das Team von IRprint bietet für geschäftliche Dokumente einen persönlichen Service mit langjähriger Finanzmarktexpertise – angefangen bei der Erstellung von Textinhalten bis hin zum professionellen Druck sowohl im Digital- als auch Offsetdruckverfahren.

Nutzen Sie unser Knowhow in der Kapitalmarktkommunikation und unsere exklusive Kooperation mit CEWE, Europas Marktführer im Bereich Fotoservice mit herausragender Expertise im kommerziellen Online-Druck. So gelingt Ihnen sowohl inhaltlich als auch optisch ein glänzender Auftritt.

GBC im Fokus

SYGNIS AG will mit Innova-Übernahme Synergieeffekte heben

Die SYGNIS AG plant, mit den aktuellen Kapitalerhöhungen (bis zu 10 Mio. €) den Erwerb der Innova Biosciences Ltd. zu finanzieren, eines Spezialisten aus dem Bereich der Proteinmarkierung. Mit dem Erwerb des profitablen Unternehmens sollen Synergieeffekte gehoben, der Workflow erweitert und darüber hinaus die operativen Kennzahlen verbessert werden. Sowohl im Peer-Group-Vergleich als auch innerhalb eines DCF-Bewertungsmodells stufen wir den Kaufpreis als sehr attraktiv ein.

Aktueller Webcast

Douglas Holding AG

6M Interim Financial Results

24. Mai 2017

Aktuelle Research-Studie

Original-Research: FinTech Group AG (von GBC AG): BUY FinTech Group AG

29. Mai 2017